Hancock Whitney Corp Decreases Stake in UnitedHealth Group Incorporated $UNH

Key Points

• Hancock Whitney Corp reduced its stake in UnitedHealth Group by 12.8%, selling 1,099 shares, and now holds a total of 7,496 shares valued at approximately $3.93 million.
• Vanguard Group Inc. and other institutional investors are actively modifying their holdings, with Vanguard increasing its stake by 6.6% to over 90 million shares, valued at $47.5 billion.
• UnitedHealth Group announced a quarterly dividend of $2.21, yielding 2.9%, with the record date set for September 15th.

Hancock Whitney Corp trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 12.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 7,496 shares of the healthcare conglomerate's stock after selling 1,099 shares during the period. Hancock Whitney Corp's holdings in UnitedHealth Group were worth $3,926,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Brighton Jones LLC boosted its holdings in shares of UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC boosted its position in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after purchasing an additional 2,324 shares in the last quarter. Algert Global LLC boosted its holdings in UnitedHealth Group by 5.3% in the fourth quarter. Algert Global LLC now owns 3,175 shares of the healthcare conglomerate's stock worth $1,606,000 after acquiring an additional 160 shares in the last quarter. CoreCap Advisors LLC lifted its holdings in shares of UnitedHealth Group by 127.5% during the fourth quarter. CoreCap Advisors LLC now owns 3,553 shares of the healthcare conglomerate's stock worth $1,797,000 after purchasing an additional 1,991 shares during the period. Finally, Deprince Race & Zollo Inc. lifted its holdings in shares of UnitedHealth Group by 6.3% during the fourth quarter. Deprince Race & Zollo Inc. now owns 81,222 shares of the healthcare conglomerate's stock worth $41,087,000 after purchasing an additional 4,817 shares during the period. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

NYSE:UNH traded up $23.95 during mid-day trading on Tuesday, reaching $344.20. 22,323,902 shares of the stock were exchanged, compared to its average volume of 12,860,278. The company has a 50 day simple moving average of $288.96 and a 200-day simple moving average of $371.54. The stock has a market capitalization of $311.74 billion, a P/E ratio of 14.90, a P/E/G ratio of 2.04 and a beta of 0.45. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter in the prior year, the business earned $6.80 EPS. The company's quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio is 38.30%.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on UNH shares. Royal Bank Of Canada lowered their price target on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Robert W. Baird restated an "underperform" rating and issued a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Baird R W cut UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. Hsbc Global Res cut UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a report on Wednesday, May 21st. Finally, Wall Street Zen cut UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $355.77.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.